|Articles|May 10, 2022

Daily OTC Pearl: Oxy-Powder

Oxy-Powder is designed to clean the digestive tract and oxidize and decrease the amount of impacted fecal matter.

OTC/Lifestyle Pearl of the Day: Oxy-Powder

Indication: Oxy-Powder is designed to clean the digestive tract and oxidize and decrease the amount of impacted fecal matter.

Insight:

Cleanses and detoxifies to support a healthy gut.
Oxy-Powder is made with vegetable capsules that are easy-to-swallow, gentle, and dissolve quickly.
Ingredients: Elemental magnesium, natural citric acid, gum acacia, Kosher certified, gluten-free capsules.

Source:

Oxy-Powder® | Oxygen Based Natural Colon Cleanse Supplement – Global Healing

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Virtual Symposium Registration

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

Friday, September 11, 2026 | 12:10 PM – 1:10 PM EDT

Virtual Symposium Registration

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Friday, September 11, 2026 | 7:00 AM – 8:00 AM EDT

Virtual Event

Directions in Oncology Pharmacy® 2026 Midwest

Saturday, September 19, 2026 | 8:00 AM – 2:00 PM CT

Webinar Registration

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Thursday, September 10 | Tuesday, September 22, 2026 at 1:00 PM and 8:00 PM EDT

Virtual Event

Infectious Disease Day of Education 2026

Thursday, September 24, 2026

Virtual Symposium Registration

Continuing the Conversation—Breaking Barriers in Obesity Management: Localizing Care, Maximizing Treatment Access, and Sustaining Adherence

Friday, October 2, 2026 | 1:00 PM – 2:30 PM EDT

Webinar Registration

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Monday, October 5, 2026 | 1:00 PM & 8:00 PM EDT

Webinar Registration

Access and Formulary Design Considerations for Nonsteroidal Topical Therapies in Dermatology

Monday, October 12, 2026 | 1:00 PM & 8:00 PM EDT

Webinar Registration

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Webinar Registration

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

In-Person + Virtual Event

AMCP Nexus 2026

October 27-28, 2026

Virtual Event

Specialty Pharmacy Day of Education 2026

Thursday, November 5, 2026

Daily OTC Pearl: Oxy-Powder

Related Content

As Measles Cases Surge, Pharmacists Are Stepping Up to Close the Vaccination Gap

Phase 3 Trial Shows Oral Deucrictibant Reduces Hereditary Angioedema Attacks by 83%

COVID-19 Infection Linked to Lower Risk of T1D in Those Younger Than 30

High-Dose Influenza Vaccine Lowers Hospitalization Risk in Older Adults With Chronic Lung Disease

Arlo-Cel Meets Response End Points in Heavily Pretreated Myeloma

Latest CME

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Directions in Oncology Pharmacy® 2026 Midwest

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Infectious Disease Day of Education 2026

Continuing the Conversation—Breaking Barriers in Obesity Management: Localizing Care, Maximizing Treatment Access, and Sustaining Adherence

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Access and Formulary Design Considerations for Nonsteroidal Topical Therapies in Dermatology

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

AMCP Nexus 2026

Specialty Pharmacy Day of Education 2026

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

Advancing HER2-Driven Cancer Care, Biomarker Testing, and Pharmacist Innovation

Stop and Smell the ROSis: Translating Molecular Results Into Actionable Pharmacy Practice in ROS1-Rearranged NSCLC

Navigating Outpatient Bispecific Antibody Administration in Lymphoma: Practical Solutions for Community Oncology Practices

2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Infectious Disease Day of Education 2026

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Minimizing Injection Burden: Anti-VEGF Innovation for Retinal Disease Management

Beyond the Nasal Passage: Managing Chronic Rhinosinusitis With Nasal Polyps With Biologics and Pharmacist-Led Approaches

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations (Pharmacy Technician Credit)

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations

PBMI 2026

Directions in Oncology Pharmacy® 2026 West Coast

Lung Cancer Day of Education 2026

ASCP 2026

Specialty Pharmacy Day of Education 2026

Advancing Patient Safety: Strategies to Address Safety Risks and Adherence Barriers to Optimize Outcomes for Patients on Injectable Therapies

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Exploring Immunotherapy Strategies in Endometrial Cancer

Pharmacogenomics in Practice: Enhancing Patient Care Through Genetic Insights

New Oncology Therapy Approvals for 2025 (Pharmacist Credit)

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

The Pharmacist's Role in Palliative and End of Life Symptom Management